News | July 16, 2022
Merck and Orion collaborate for the development and commercialization of ODM-208
Orion to receive an upfront payment of USD 290 million
Orion to receive an upfront payment of USD 290 million
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
Younger Indians have a 10 times higher rate of heart attack
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
First and only PARP inhibitor to improve invasive disease-free survival in patients
Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients
LYNPARZA is approved in the U.S. for patients with HRR gene-mutated mCRPC (BRCA-mutated and other HRR gene mutations)
Atik Cameras launches ChemiMOS; A 9MP CMOS camera for scientific applications
48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
Acceptance based on results from the phase 3 KEYNOTE-091 trial
Subscribe To Our Newsletter & Stay Updated
